Remove 2024 Remove Drug Development Remove Testimonials
article thumbnail

New Years Resolutions Medical Device Marketers Should Make in 2024 

Perficient: Drug Development

A few weeks back, I wrote about key trends that would impact the medical device world in 2024. This time around, I’m going to be counting down some 2024 resolutions for medical device marketers. One way is to lean into consumer quotes and testimonials, whether patients or clinical profiles. So how can you strike the balance?

article thumbnail

Analysis Life Sciences Thank You What We Expect the FDA to do in July 2023

Agency IQ

to provide notice and an opportunity for owners or consignees of the drug to appear before the Agency and introduce testimony prior to the destruction of their drug. OIG claims a review will be complete in 2024. The final rule will amend the administrative destruction provisions in 21 CFR 1.94

FDA 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Analysis Life Sciences Thank You What We Expect the FDA to do in October 2023

Agency IQ

AgencyIQ November 27 DSCSA Technically goes into full effect While the FDA has technically extended enforcement of certain provisions under the Drug Supply Chain Security Act until November 2024, certain provisions of the law are still due to come into effect in late November. Review to take place within 21 days. to include devices.

FDA 40
article thumbnail

Analysis Life Sciences Thank You What We Expect the FDA to do in November 2023

Agency IQ

and Annex 1 Conference Joel Welch December 18 RAPS RAPS Webcast: FDA Forecast: What’s Next for the FDA in 2024 AgencyIQ Speakers December 21 HL7 REMS Public Call PDUFA Dates expected in November and December PDUFA dates represent the expected date of a regulatory decision by the FDA on a New Drug Application or Biologics License Application.

FDA 40
article thumbnail

Analysis Life Sciences Thank You What We Expect the FDA to do in December 2023

Agency IQ

and Annex 1 Conference Joel Welch December 12 AgencyIQ Looking ahead to 2024: Regulatory Forecast for the U.S. and Annex 1 Conference Joel Welch December 12 AgencyIQ Looking ahead to 2024: Regulatory Forecast for the U.S. Morgan Chase 42 nd Annual J.P.

FDA 40
article thumbnail

React v19: A Game-Changer for React Developers !

Perficient: Drug Development

React 19 has officially been released as a stable version on December 5, 2024. This update introduces amazing features that enhance the developer experience and application performance. If CourseWrapper takes longer to receive its data, CourseList and Testimonials cannot render until CourseWrapper completes.

article thumbnail

Key Takeaways – Expanding CAR T Beyond Oncology: Medical, Operational, & Practical Considerations

Conversations in Drug Development Trends

Current CAR T Landscape & Growth Trends CAR T therapies are witnessing an impressive surge of growth, with 2024 marking a record number of these studies. Tahseen Mozaffar of UC Irvine in an on-demand webinar, Expanding CAR T Beyond Oncology: Medical, Operational & Practical Considerations.